Shahjada Selim

9PUBLICATIONS
37CO-AUTHORS
Major global burdens of diseaseBehavioural epidemiologyCancer geneticsEpidemiological methodsPublic health nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2026
Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh.

Shahjada Selim, Muhammad Hafizur Rahman, Marufa Mustari

|Dec 04, 2025
Safety and effectiveness of tirzepatide during Ramadan fasting: Real-world evidence from patients with type 2 diabetes in Bangladesh.

Muhammad Hafizur Rahman, Shahjada Selim, Faria Afsana

|Nov 27, 2025
Recurrent Nephrolithiasis and Beyond: The Long Diagnostic Odyssey of a Case of CLDN16 Mutation.

Abdullah Al Noman Bhuiyan, Nazia Akter, Tahniyah Haq

|Oct 02, 2024
Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis.

A B M Kamrul-Hasan, Muhammad Shah Alam, Samir Kumar Talukder

|Jan 31, 2024
Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study.

Mohammed Farid Uddin, Murshed Ahamed Khan, Shahjada Selim

|Dec 05, 2023
Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.

Shahjada Selim, Muhammad Shah Alam, Samir Kumar Talukder

Pageof 2

Frequent Collaborators

5 joint publications

A B M Kamrul-Hasan

4 joint publications

Mohammad Abdul Hannan

3 joint publications

Afsar Ahammed

3 joint publications

Samir Kumar Talukder